We performed survival analysis on half of the patients with high expression levels and half of the patients with low expression levels of candidate DEGs and found that the expression of PECAM-1 had a significant impact on the survival of patients with LC at the threshold expression value of 8,615 (Figures 6A–D). Here, PECAM1 is linked to laryngotracheoesophageal cleft.